Bharat Immunologicals (India) Financial Diagnostics

BIBCL -- India Stock  

INR 6.91  0.24  3.60%

The big decline in price over the last few months for Bharat Immunologicals could raise concerns from investors as the firm closed today at a share price of 6.6 on 3645.000 in volume. The company management failed to add value to investors and positioning the firm components to exploit market volatility in June. However, diversifying your holdings with Bharat Immunologicals Biologicals Corp Ltd or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 4.5501. This high volatility is attributed to the latest market swings and not so good earning reports for some of the Bharat Immunologicals partners. This diagnostics interface makes it easy to digest most current publicly released information about Bharat Immunologicals as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Bharat Immunologicals price relationship with some important fundamental indicators such as market cap and management efficiency. Check also Trending Equities.

Bharat Immunologicals Note

The company has price-to-book (P/B) ratio of 0.91. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bharat Immunologicals has Price/Earnings (P/E) ratio of 262.88. The entity recorded loss per share of 1.29. The firm had not issued any dividends in recent years. Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. Bharat Immunologicals operates under Biotechnology classification in India and is traded on Bombay Stock Exchange. For more info on BHARAT IMUNO(BSE please contact the company at 91 57 3223 8757 or go to http://bibcol.in.

Bharat Immunologicals Alerts

Bharat Immunologicals generates negative expected return over the last 30 days
Bharat Immunologicals has high historical volatility and very poor performance
The company reported revenue of 836.45M. Net Loss for the year was (55.57M) with profit before overhead, payroll, taxes, and interest of 103.65M.
Latest headline from www.digitaljournal.com: Pediatric Vaccines 2019 Market Highlights by New Innovations, Leading Growth Drivers, Emerging Technology, Latest Trends Forecast to 2023 - Press Release - Digital Journal

Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 310.9M.

Profitablity

The company has Profit Margin (PM) of (6.64) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (11.0) % which suggests for every $100 dollars of sales it generated a net operating loss of -0.11.

Management Efficiency

Bharat Immunologicals has return on total asset (ROA) of (9.86) % which means that it has lost $9.86 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (10.18) % meaning that it generated substantial loss on money invested by shareholders.

Technical Drivers

As of 20 of July Bharat Immunologicals shows Mean Deviation of 2.6 and Risk Adjusted Performance of (0.09). Bharat Immunologicals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. Please confirm Bharat Immunologicals Jensen Alpha, Semi Variance and the relationship between Standard Deviation and Value At Risk to decide if Bharat Immunologicals is priced correctly providing market reflects its regular price of 6.91 per share.

Bharat Immunologicals Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
The output start index for this execution was eleven with a total number of output elements of twenty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bharat Immunologicals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bharat Immunologicals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Bharat Immunologicals Technical and Predictive Indicators

Bharat Immunologicals Forecast Models

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine historical correlation between any two equity instruments
All  Next Launch Module
Check also Trending Equities. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com